Carlyle Group Confronts Rising Exits, Falling Exit Values and Compressed Returns

Carlyle Confronts a Market of More Exits but Lower Returns

Carlyle Group faces intensified pressure to monetize aging portfolios as private equity firms increase the pace of exits while accepting lower prices, industry data show. S&P Global Market Intelligence reports global private equity exits rise 5.4% in 2025 to 3,149 deals even as total exit value falls 21.2% to $412.1 billion, reflecting a market where sellers are more willing to take smaller proceeds to generate liquidity. For Carlyle, which manages large vintage portfolios, the dynamic forces a choice between accelerating realizations at reduced gains or holding assets longer in hopes of valuation recovery.

The firm and its peers are adjusting strategies to navigate the valuation gap created after the 2022 S&P 500 plunge and subsequent deferred markdowns, analysts say. Larger sponsors such as Blackstone are already reporting significant realizations by selling sizable, saleable assets, an approach Carlyle can emulate; alternatively, firms increasingly pursue GP-led secondaries, carve-outs of premium assets or accept lower exit prices to shorten fund lifecycles. The trade-offs are immediate: quicker cash returns to limited partners come with compressed returns, while patience risks longer fund durations and continued pressure on reported marks.

Carlyle’s fundraising and fee model face potential recalibration as limited partners grow more cautious and demand greater transparency. S&P data show a related 11% drop in private equity fundraising in 2025 to $490.81 billion, driven in part by tens of thousands of companies on sponsor books that depress cash returned to investors. That environment prompts firms like Carlyle to consider more conservative valuation practices, faster realizations and increased secondary-market activity to satisfy LPs and support future fund-raising.

Wider market metrics underline the shift: PwC notes U.S. private equity deal value grows concentratedly while deployment counts remain flat, signaling success on larger transactions but stagnation broadly. The backlog of assets and lower exit valuations are compressing returns across the industry and contributing to a recalibration of expectations among investors.

Market observers say the sector is in a transitional period that could permanently reshape fundraising dynamics, fee structures and secondary market volumes. High-profile public exits such as Medline’s Nasdaq listing in December 2025 exemplify a market searching for pathways to liquidity as firms balance patience against an urgent need to deliver cash to investors.